On July 27, 2022 Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, reported that it will present at the following investor conferences in August (Press release, Delcath Systems, JUL 27, 2022, View Source [SID1234617645]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

BTIG Biotechnology Conference 2022 on August 9, 2022.
Canaccord Genuity 42nd Annual Growth Conference: Presentation to take place on August 10, 2022 at 12:30PM ET. A webcast of the presentation will be available at: View Source
To learn more or to schedule a one-on-one meeting with management, please contact your conference representative or [email protected].